GENMAB AS SP.ADR/1/10DK 1 (GE91) — Defensive Interval Ratio
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Defensive Interval Ratio of 284 days as of December 2025. Defensive assets of €1.11 Billion (cash €-, short-term investments €0.00, receivables €1.11 Billion) cover 284 days of daily cash needs of €3.91 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
GENMAB AS SP.ADR/1/10DK 1 Defensive Interval Ratio (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 284 days, meaning defensive assets of €1.11 Billion can fund 284 days of operations without new revenue. For the complete balance sheet picture, see total assets of GENMAB AS SP.ADR/1/10DK 1.
Annual Defensive Interval Ratio for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See GENMAB AS SP.ADR/1/10DK 1 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 284 days | €1.11 Billion | €3.91 Million/day | €- | €0.00 | ▼ -944 days |
| 2024 | 1228 days | €2.49 Billion | €2.03 Million/day | €- | €1.57 Billion | ▼ -1447 days |
| 2023 | 2675 days | €2.70 Billion | €1.01 Million/day | €- | €1.97 Billion | ▼ -958 days |
| 2022 | 3633 days | €2.61 Billion | €718.85K/day | €- | €1.79 Billion | ▲ +432 days |
| 2021 | 3200 days | €2.09 Billion | €653.99K/day | €- | €1.58 Billion | — |